Home > Insider Trading > Esperion Therapeutics Inc.

Esperion Therapeutics Inc. (ESPR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

Did Hedge Funds Drop The Ball On Esperion Therapeutics (ESPR) ?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.

Keep Reading →

December 12th, 2019 - Hedge Funds News

Should You Buy Esperion Therapeutics, Inc. (ESPR)?

Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.

Keep Reading →

October 28th, 2019 - Hedge Funds News

Hedge Fund and Insider Trading News: David Einhorn, Caxton Associates, Crown Castle International Corp (CCI), Esperion Therapeutics Inc (ESPR), and More

David Einhorn sniffed out fixed income trouble in 2008 and sees more ahead in the US corporate bond market. In fact, the hedge fund chieftain is shorting corporate debt.

Keep Reading →

July 26th, 2019 - Hedge Funds Insider Trading

Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy?

The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive database.

Keep Reading →

July 5th, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Esperion Therapeutics, Inc. (ESPR)

How do we determine whether Esperion Therapeutics, Inc.

Keep Reading →

May 2nd, 2019 - Hedge Funds News

Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy?

Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required...

Keep Reading →

December 19th, 2018 - Hedge Funds News

Hedge Fund and Insider Trading News: Jonathan Litt, Mike Novogratz, The Medicines Company (MDCO), Checkpoint Therapeutics Inc (CKPT), Koppers Holdings Inc. (KOP), and More

Nov 28 (Reuters) - Activist investor Jonathan Litt on Wednesday renewed call for the sale of the Saks Fifth Avenue brand, while asking owner Hudson’s Bay Co to make new board appointments, saying the...

Keep Reading →

November 28th, 2018 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Crispin Odey, Cerrano Capital, WideOpenWest Inc (WOW), Constellation Pharmaceuticals Inc (CNST), Caesars Entertainment Co. (CZR), and More

LONDON (Reuters) - Sterling and UK government bonds will fall further in the run-up to Brexit, even after the pound slumped this week to its lowest in almost a year, prominent Brexit-supporting British...

Keep Reading →

August 9th, 2018 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Elliot Management, Brevan Howard, Acorda Therapeutics Inc (ACOR), Cognizant Technology Solutions Corp (CTSH), and More

Elliott Management Corp., the hedge fund founded by billionaire Paul Singer, has built a stake in Sky Plc as shareholders prepare to vote on 21st Century Fox Inc.’s 11.7-billion-pound ($16.6 billion...

Keep Reading →

January 29th, 2018 - Hedge Funds Insider Trading